EUVIMEDEUVIMED entdecken
Crossref

Scale-Up of Nanopharmaceutical Formulations: Integrating Critical Quality Attributes, Process Analytical Technology, and Regulatory Challenges into a Decision Framework

Arbaz Khan

TMP Universal Journal of Advances in Pharmaceutical Sciences · 17.12.2026 · 2 (4)

DOI: 10.69557/6wqvtk56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TMP Universal Journal of Advances in Pharmaceutical Sciences, online erschienen am 17.12.2026. Verfasst von Arbaz Khan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanopharmaceuticals are generally successful at laboratory scale, but once production levels rise, their quality suffers, and the reasons for this are seldom explored in relation to monitoring and regulatory requirements. This critical review considers 90 peer-reviewed sources, 77 of which are published from 2020 onward, and explores the relationship between formulation composition, process conditions, particle attributes, in-process monitoring, and regulatory expectations during scale-up. The size, polydispersity, payload integrity and storage stability of lipid nanoparticles, liposomes, polymeric nanoparticles, nanoemulsions and nanocrystals respond differently to changes in mixing, shear, filtration time and freezing history. Quality-by-design studies rarely report design spaces at production scale and most process analytical technology work is focused on particle size, while encapsulation, payload integrity and lipid quality are still tested offline. Nanomedicines are regulated on a case-by-case basis in regulatory documents and no harmonized comparability pathway exists. An unvalidated framework is presented in the review linking material attributes, process parameters, quality attributes, monitoring tier and comparability evidence through a decision matrix and decision-flow diagram. The framework identifies scale sensitive, history sensitive and material sensitive attributes and assigns a monitoring and control strategy to each of them. The priority research needs are inline methods for payload integrity, scale-transferable design spaces, validated digital models and agreed comparability criteria. The proposals have to be tested in prospective real manufacturing programs.

Zitieren

APA

Khan, A. (2026). Scale-Up of Nanopharmaceutical Formulations: Integrating Critical Quality Attributes, Process Analytical Technology, and Regulatory Challenges into a Decision Framework. TMP Universal Journal of Advances in Pharmaceutical Sciences, 2(4). https://doi.org/10.69557/6wqvtk56

Vancouver

Khan A. Scale-Up of Nanopharmaceutical Formulations: Integrating Critical Quality Attributes, Process Analytical Technology, and Regulatory Challenges into a Decision Framework. TMP Universal Journal of Advances in Pharmaceutical Sciences. 2026;2(4). doi:10.69557/6wqvtk56

BibTeX
@article{Khan2026,
  author = {Khan, Arbaz},
  title = {Scale-Up of Nanopharmaceutical Formulations: Integrating Critical Quality Attributes, Process Analytical Technology, and Regulatory Challenges into a Decision Framework},
  journal = {TMP Universal Journal of Advances in Pharmaceutical Sciences},
  year = {2026},
  volume = {2},
  number = {4},
  doi = {10.69557/6wqvtk56}
}
Kostenlos starten →